Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients
- 1 September 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (5) , 287-295
- https://doi.org/10.1038/sj.bmt.1703633
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 31 references indexed in Scilit:
- New strategies in GVHD prophylaxisBone Marrow Transplantation, 2000
- Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimusBone Marrow Transplantation, 1999
- Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Improving the Outcome of Bone Marrow Transplantation by Using CD52 Monoclonal Antibodies to Prevent Graft-Versus-Host Disease and Graft RejectionBlood, 1998
- Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisBone Marrow Transplantation, 1998
- Low Transplant Mortality in Allogeneic Bone Marrow Transplantation for Acute Myeloid Leukemia: A Randomized Study of Low-Dose Cyclosporin Versus Low-Dose Cyclosporin and Low-Dose MethotrexateBlood, 1998
- Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized TrialBlood, 1997
- The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisoneBlood, 1995
- What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?Blood, 1990
- Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseBlood, 1988